Vibrant Gastro announced today the publication of new real-world evidence in Clinical and Translational Gastroenterology demonstrating the long-term effectiveness and safety of the Vibrant System™, a ...

Millions of adults all over the world endure chronic constipation — an awkward situation marked by hard, painful, or infrequent bowel movements which disrupt daily life. Even though prevalent, advice ...

New guidelines have been published for managing chronic idiopathic constipation (CIC), a common disorder that affects 8% to 12% of adults in the United States. The guida n ce, authored by experts with ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

Gastroenterologist Joe Soliman, MD, answers questions about when to treat chronic idiopathic constipation (CIC) and what your options are. Most everyone gets constipated from time to time. When does ...

LEXINGTON, Mass., April 2, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., ("Takeda") today announced that Motegrity ™ (prucalopride), a once-daily, oral treatment option, is now ...

Patients often arrive in pain, miserable, and desperate for relief from constipation. Defined as fewer than three bowel movements per week lasting more than 4 weeks, chronic constipation affects about ...

New guidelines on what to eat and drink if you have chronic (long-term) constipation have been making news in recent days.

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...